Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
DOI: 10.1016/S0140-6736(24)02575-3
文献链接:
其他信息:
出版社: Elsevier BV
作者: Masatoshi Kudo; Zhenggang Ren; Yabing Guo; Guohong Han; Hailan Lin; Jinfang Zheng; Sadahisa Ogasawara; Ji Hoon Kim; Haitao Zhao; Chuan Li; David C Madoff; R Mark Ghobrial; Tomokazu Kawaoka; René Gerolami; Masafumi Ikeda; Hiromitsu Kumada; Anthony B El-Khoueiry; Arndt Vogel; Xiang Peng; Kalgi Mody; Corina Dutcus; Leonid Dubrovsky; Abby B Siegel; Richard S Finn; Josep M Llovet